Why Is Ceragon Networks Surging By 19%? 41 Stocks Moving In Tuesday's Mid-Day Session


  • Agile Therapeutics, Inc. AGRX jumped 88.9% to $2.3986. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade.
  • Kezar Life Sciences, Inc. KZR shares jumped 73.3% to $10.02 after the company announced topline results from the MISSION Phase 2 clinical trial evaluating zetomipzomib.
  • Tuniu Corporation TOUR rose 54.2% to $0.8017 following reports suggesting China will ease some COVID quarantine requirements for international travelers.
  • HTG Molecular Diagnostics, Inc. HTGM gained 47% to $0.8117.
  • Grom Social Enterprises, Inc. GROM surged 31.6% to $0.5800.
  • Endo International plc ENDP climbed 26.3% to $0.4839.
  • Decibel Therapeutics, Inc. DBTX surged 22.7% to $2.75 after reporting data from interim analysis of Phase 1b clinical trial of DB-020.
  • Bird Global, Inc. BRDS gained 22.5% to $0.5805.
  • Benitec Biopharma Inc. BNTC jumped 22% to $1.8808.
  • Petros Pharmaceuticals, Inc. PTPI gained 19.6% to $0.9796. Petros Pharmaceuticals said it received letter from listing qualifications department of the Nasdaq stock market that the company did not meet the minimum bid price of $1.00/share required for continued listing.
  • Ceragon Networks Ltd. CRNT shares rose 19.1% to $2.49 after Aviat Networks, Inc. proposed to acquire the company for $2.80 per share in cash.
  • The9 Limited NCTY surged 17.3% to $2.3695.
  • Centogene N.V. CNTG gained 16.8% to $2.50. CENTOGENE announced appointment of Miguel Coego Rios as Chief Financial Officer.
  • Sera Prognostics, Inc. SERA surged 16.3% to $2.51.
  • Sutro Biopharma, Inc. STRO gained 16.2% to $5.03. Astellas Pharma and Sutro Biopharma announced a strategic collaboration and licensing agreement focused on the discovery and development of immunostimulatory antibody-drug conjugates (iADC).
  • Trip.com Group Limited TCOM rose 15% to $28.24 after reporting a rise in Q1 sales.
  • Greenwich LifeSciences, Inc. GLSI gained 14% to $10.09.
  • Mesa Royalty Trust MTR surged 13% to $12.83.
  • SOPHiA GENETICS SA SOPH surged 12.7% to $3.83.
  • Lands' End, Inc. LE gained 11.8% to $12.70. Lands' End announced a $50 million buyback authorization.
  • BiomX Inc. PHGE jumped 11% to $0.8099 after the company announced a collaboration with Boehringer Ingelheim to identify biomarkers for inflammatory bowel disease.
  • Melco Resorts & Entertainment Limited MLCO rose 10.6% to $6.49 following reports suggesting China will ease quarantine requirements for international travelers.
  • InflaRx N.V. IFRX rose 9.3% to $1.18 after jumping 38% on Monday. InflaRx was granted FDA Orphan Drug Designation on Monday for the treatment of pyoderma gangrenosum.
  • Benitec Biopharma Inc. BNTC gained 7.8% to $1.6599 after jumping 26% on Monday.
  • ENDRA Life Sciences Inc. NDRA rose 7.1% to $0.2410.


  • Lytus Technologies Holdings PTV. Ltd. LYT shares fell 33.5% to $31.27. Lytus recently announced the closing of initial public offering.
  • Cognyte Software Ltd. CGNT fell 28% to $4.58 after the company reported worse-than-expected Q1 results.
  • Genenta Science S.p.A. GNTA dropped 18.7% to $6.46.
  • IT Tech Packaging, Inc. ITP shares fell 17.1% to $0.1227. IT Tech Packaging reported a 1-for-10 reverse stock split, effective July 7.
  • Revlon, Inc. REV fell 16.5% to $5.60. Reliance Industries, in a press release, declined comment on rumor of Revlon takeover interest.
  • Boxed, Inc. BOXD dipped 14.7% to $2.0550.
  • Aspira Women's Health Inc. AWH dipped 14.3% to $0.5834. Aspira Women's Health shares traded higher on Monday amid the Supreme Court overturning Roe V Wade.
  • Scholar Rock Holding Corporation SRRK dropped 14.2% to $6.30. Scholar Rock Holding shares traded higher on Monday following the purchase of 1,497,490 shares and warrants by a company director, which was disclosed late Friday.
  • Phoenix Motor Inc. PEV declined 12.9% to $5.83.
  • Hillstream BioPharma, Inc. HILS dropped 12.4% to $0.7795. Hillstream BioPharma shares traded higher on Monday after the company announced a collaboration with Sapien Biosciences in cancer treatments to evaluate the synergy of HSB-1216 with immune checkpoint inhibitors.
  • NextPlay Technologies, Inc. NXTP declined 11.2% to $0.3886.
  • Heliogen, Inc. HLGN dropped 10.6% to $2.76.
  • ToughBuilt Industries, Inc. TBLT fell 10.5% to $2.64 after gaining over 9% on Monday. ToughBuilt recently priced a $6 million offering.
  • Grove Collaborative Holdings, Inc. GROV dropped 10% to $5.47. Telsey Advisory Group recently initiated coverage on Grove Collaborative with an Outperform rating and announced a price target of $10.
  • NGM Biopharmaceuticals, Inc. NGM declined 9.9% to $13.27.
  • Enerpac Tool Group Corp. EPAC dropped 7.4% to $18.30 following downbeat Q3 results.

Posted In: Mid-Day MoversTop GainersNewsPenny StocksSmall CapIntraday UpdateMarketsMoversTrading Ideas

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.